Estrace combined with Medroxyprogesterone

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Breast Cancer Female Other Serious Female 2/1/2006 United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 2/1/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 9/1/2001 54 Female 120 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 5/1/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/4/2002 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 12/16/1999 Female 12/23/2005 United States
Primary
Secondary
Cerebrovascular Accident Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2000 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 7/1/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/24/2000 Female 2/22/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2004 Female 3/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 9/1/2001 63 Female 158 lb 12/23/2005 United States
Primary
Secondary
Breast Tenderness Other Serious 9/1/2003 61 Female 182 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/2/2001 64 Female 4/11/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 10/4/2002 Female 2/8/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/12/2006 United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 4/21/2006 Physician United States
Primary
Secondary
Concomitant
Metastases To Lymph Nodes Other Serious 7/18/2003 55 Female 5/12/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/1/2001 Female 3/7/2006 Lawyer United States
Primary
Secondary
Breast Cancer In Situ Other Serious 7/17/1998 59 Female 5/24/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 5/30/1996 66 Female 5/25/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 4/4/2005 57 Female 5/25/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 12/16/1999 Female 5/31/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 10/31/2000 Female 5/31/2006 United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 6/1/2006 Physician United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 5/30/1996 Female 6/2/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 7/18/2003 55 Female 6/9/2006 United States
Primary
Secondary
Ovarian Cancer Other Serious 6/24/2003 Female 6/26/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 7/18/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 7/18/2003 55 Female 7/19/2006 United States
Primary
Secondary
Breast Cancer Other Serious 6/2/2001 64 Female 7/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Required Intervention 1/14/2002 54 Female 145 lb 7/7/2006 United States
Primary
Secondary
Concomitant
Staphylococcal Infection Other Serious 10/25/2001 59 Female 7/27/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/17/1999 68 Female 8/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2001 69 Female 8/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2001 55 Female 8/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 10/20/2004 59 Female 8/8/2006 Consumer United States
Primary
Secondary
Contralateral Breast Cancer Other Serious 11/1/2001 69 Female 8/3/2006 United States
Primary
Secondary
Breast Cancer Other Serious 7/18/2003 Female 7/21/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2005 56 Female 7/21/2006 Consumer United States
Primary
Secondary
Breast Cancer Required Intervention 7/1/2003 Female 7/21/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2002 Female 7/21/2006 Lawyer United States
Primary
Secondary
Ovarian Cancer Other Serious 5/4/2000 Female 8/8/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 2/1/2002 55 Female 8/14/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2001 74 Female 8/9/2006 United States
Primary
Secondary
Ovarian Cancer Other Serious 5/4/2000 Female 8/17/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2002 55 Female 8/14/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 10/20/2004 59 Female 8/21/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 9/24/2002 Female 9/7/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 1/1/2005 Female 9/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2005 Female 9/25/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 6/2/2001 Female 156 lb 12/30/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 6/1/2005 51 Female 12/22/2006 United States
Primary
Secondary
Malignant Breast Lump Removal Other Serious 5/10/1996 57 Female 8/31/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 10/28/1999 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2001 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/24/2002 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2000 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 7/17/1998 52 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/19/2001 55 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/20/2004 59 Female 1/12/2007 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/6/2000 66 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/10/2001 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2001 51 Female 140 lb 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/7/2003 67 Female 160 lb 10/10/2006 United States
Primary
Secondary
Death Other Serious 10/20/2004 59 Female 1/18/2007 Consumer United States
Primary
Secondary
Injury Other Serious 10/28/1999 9/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2001 Female 1/29/2007 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 8/27/2002 67 Female 2/7/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2001 Female 165 lb 2/22/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 3/1/2001 Female 2/22/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious 4/22/2003 Female 3/8/2007 Lawyer United States
Primary
Secondary
Breast Operation Other Serious Female 10/30/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 6/26/2002 61 Female 128 lb 12/22/2006 United States
Primary
Secondary
Pulmonary Embolism Hospitalization 6/14/1999 63 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2001 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2000 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/1998 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 6/4/2002 64 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/13/2001 63 Female 158 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/4/2005 57 Female 12/22/2006 United States
Primary
Secondary
Weight Increased Other Serious 8/5/1994 56 Female 130 lb 4/14/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Death 10/20/2004 59 Female 1/31/2007 Consumer United States
Primary
Secondary
Radiotherapy Other Serious 4/22/1994 57 Female 135 lb 5/10/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 6/26/2004 Female 5/10/2007 Lawyer United States
Primary
Secondary
Breast Cancer In Situ Other Serious 12/27/2001 56 Female 138 lb 2/7/2007 Physician United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/2000 59 Female 156 lb 2/7/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Required Intervention 1/1/2001 Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer In Situ Required Intervention 1/1/1998 59 Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary

Drug Data